ArticleJournal of medical systems2018
A Novel Vision-Enhancing Technology for Low-Vision Impairments.
Article in Journal of medical systems, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ocular disorders such as vitreoretinal pathologies are widespread, especially in older adults. In particular, degenerative diseases of the retina such as macular senile degenerations are on the rise and affect millions of people with hundreds of thousands of new cases each year. These diseases can cause profoundly disabling visual impairments, in some cases severely compromising the central and/or the peripheral vision in one or both eyes. In this paper, we present a novel vision aids technology that allows for correcting or attenuating the perception of visual field defects due to ocular pathologies of diverse origins or traumas by using techniques of 3D visualisation, eye tracking, and image processing. The presented technology is mainly conceived for providing vision aids that can significantly improve the quality of life of people with this kind of visual disorders. As well, it could be employed for supporting the diagnosis of ocular dysfunctions and for monitoring the progression of diseases. The technology shown in this work is protected by an International Application in Patent Cooperation Treaty (PCT).
Indexed as
Identifiers
30406503What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.